Correlation Between Tandem Diabetes and SVELEV

Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and SVELEV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and SVELEV into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tandem Diabetes Care and SVELEV 13 10 FEB 28, you can compare the effects of market volatilities on Tandem Diabetes and SVELEV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of SVELEV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and SVELEV.

Diversification Opportunities for Tandem Diabetes and SVELEV

0.32

Correlation Coefficient

Tandem Diabetes  SVELEV

Weak diversification

The 3 months correlation between Tandem and SVELEV is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and SVELEV 13 10 FEB 28 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SVELEV 13 10 and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with SVELEV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SVELEV 13 10 has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and SVELEV go up and down completely randomly.

Pair Corralation between Tandem Diabetes and SVELEV

Given the investment horizon of 90 days Tandem Diabetes Care is expected to generate 16.16 times more return on investment than SVELEV. However, Tandem Diabetes is 16.16 times more volatile than SVELEV 13 10 FEB 28. It trades about 0.04 of its potential returns per unit of risk. SVELEV 13 10 FEB 28 is currently generating about 0.07 per unit of risk. If you would invest  3,285  in Tandem Diabetes Care on September 5, 2024 and sell it today you would earn a total of  52.00  from holding Tandem Diabetes Care or generate 1.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	63.64%
Values	Daily Returns

Tandem Diabetes Care  vs.  SVELEV 13 10 FEB 28

Tandem Diabetes Care

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tandem Diabetes Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

SVELEV 13 10

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SVELEV 13 10 FEB 28 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, SVELEV is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Tandem Diabetes and SVELEV

The main advantage of trading using opposite Tandem Diabetes and SVELEV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, SVELEV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SVELEV will offset losses from the drop in SVELEV's long position.

The idea behind Tandem Diabetes Care and SVELEV 13 10 FEB 28 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.